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Abstract 
Single-cell RNA-Sequencing (scRNA-Seq) has undergone major technological advances in 
recent years, enabling the conception of various organism-level cell atlassing projects. With 
increasing numbers of datasets being deposited in public archives, there is a need to address 
the challenges of enabling the reproducibility of such data sets. Here, we describe guidelines 
for a minimum set of metadata to sufficiently describe scRNA-Seq experiments, ensuring 
reproducibility of data analyses. 
 
 
Main 
scRNA-Seq experiments have many advantages over the so-called bulk RNA-Sequencing and 
microarray experiments, as they allow researchers to study gene expression at an individual 
cell, rather than at tissue level1. As the scRNA-Seq technologies are maturing, these 
experiments are becoming increasingly high-throughput and widespread. Data from an 
estimated 1400 scRNA-Seq studies have been submitted to NCBI’s Gene Expression Omnibus 
(GEO)2, EMBL-EBI’s ArrayExpress3 and the European Nucleotide Archive4 (ENA) over the 
recent years. Large collaborative efforts are taking off, such as the Human Cell Atlas (HCA)5, 
which aims at uncovering the gene expression profiles of all human cell types, the Fly Cell 
Atlas (http://flycellatlas.org/), which has similar aims for Drosophila, or the Human Biomolecular 
Atlas Program (HuBMAP)6, as well as organ-specific projects, such as the BRAIN Initiative 
Cell Census Consortium7.  
 
Meta-analyses combining data from independent scRNA-Seq studies have been performed, 
revealing that although overall conclusions from independent studies confirm each other, there 
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are differences8,9. To ensure that the results of individual scRNA-Seq studies can be 
reproduced, to allow for reuse of data generated in such experiments, and more generally, to 
enable researchers to build on previous discoveries, it is important that the necessary minimal 
information about scRNA-Seq experiments are collected and preserved together with the 
respective data. The community agreement and publication of the Minimum Information About 
a Microarray Experiment (MIAME)10 guidelines almost two decades ago, was a major 
milestone in the way functional genomics data has been reported and archived. For the last two 
decades, the functional genomics data archives at EBI and NCBI have been accepting 
microarray and bulk RNA-Seq datasets, but the emergence of protocols which can assay 
transcriptomics at single-cell resolution brings along new requirements. 
 
There is a clear need to establish minimum standards for reporting data and metadata for the 
various scRNA-Seq assays. ArrayExpress and the HCA have published online guidelines for 
technical information required for scRNA-Seq data submissions, however these are not yet 
widely adopted community standards. Such standards would serve as the guiding principles 
and would ensure the reusability of the submitted datasets, guide the adaptation of existing 
archival resources and enable reproducibility of analysis by the wider scientific community. 
Here, we propose the minimum set of single-cell metadata terms, a checklist of information 
that is used to describe a single-cell assay in sufficient detail to enable analysis of the 
transcriptomic data. These guidelines are derived from the work on building and adapting 
community resources to archive and add value to such datasets, such as ArrayExpress, the 
HCA-Data Coordination Platform and the CIRM Stem Cell Hub.  
 
Typical designs of single-cell transcriptomic experiments include the following steps: (a) single 
cell isolation; (b) addition of spike-in RNAs; (c) reverse transcription; (d) amplification; (e) 
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library construction; (f) sequencing. Depending on the exact protocol followed, different types 
of metadata need to be recorded. Figure 1 shows an overview of the main steps that define the 
experimental workflows11 for scRNA-Seq, with the variety of options used by different 
protocols. 
 
 
Figure 1. Typical design steps of single-cell transcriptomics experiments with examples for 
each step (ERCC: External RNA Controls Consortium; FACS: Fluorescence-Activated Cell 
Sorting; PCR: Polymerase Chain Reaction; UMI: Unique Molecular Identifier). 
 
 
For example, the Smart-seq2 protocol12, which is frequently used for single-cell 
transcriptomics, involves cell isolation using fluorescence-activated cell sorting (FACS) and 
the use of microwell plates to separate the single cells. Barcodes are typically not used during 
reverse transcription; amplification is done by PCR and libraries covering the full length of the 
sequences are constructed. Alternatively, microdroplet-based protocols such as the commonly 
used single-cell controller from 10x Genomics use droplets to encapsulate individual cells and 
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barcode individual molecules during reverse transcription. It uses a 3- or 5-prime tag system 
during library preparation. 
 
Taking the five main components of the MIAME and MINSEQE10 experiment model, we can 
describe a single-cell sequencing experiment with a few additions and changes (Figure 2). Each 
component is equivalent to a main experimental step. We capture information describing each 
component and link it to the relevant protocols. Definitions of the individual components and 
a list of the single-cell specific attributes that are introduced can be found in the Supplementary 
Notes document. For each field we recommend using terms from a suitable ontology (like 
NCBI taxonomy13 for species) or controlled vocabulary to prevent ambiguity. We refer to the 
Supplementary Notes document for examples of different implementations of the scRNA-Seq 
metadata guidelines.  
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Figure 2. Overview of the five main components of a MINSEQE study and the new 
components specific for single-cell experiments (highlighted in yellow), with example 
attributes. 
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The adoption of MIAME guidelines by the scientific community, including the major scientific 
journals and public archives of functional genomics data almost two decades ago14 was an 
important step towards enabling a widespread reuse of these data15. We strongly believe that 
now is the time to discuss and adopt similar guidelines for scRNA-Seq experiments, so that 
data generated in the growing number of these experiments are made available for reuse, meta-
analysis and building of value-added gene expression resources. As single-cell transcriptomics 
are increasingly combined with imaging of tissue sections or quantification of surface 
proteins16, future work will involve alignment of these standards with newly emerging 
techniques requiring new types of metadata. We also expect the standard to be expanded with 
single-cell genomic and epigenomic techniques (e.g. single-cell ATAC-seq), which are not 
covered here, to address different types of single cell assays more broadly. This would support 
the reuse and interoperability of various types of single-cell data and facilitate the development 
of atlases17,18.  
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1. Main components to describe a single-cell RNA-sequencing 
(scRNA-Seq) experiment 
 
We reuse standards already defined by MIAME/MINSEQE1 that include general information 
about the experiment and add new components and terms that are necessary for 
reproducibility and re-analysis of scRNA-Seq experiments.  
 
Taking the five main components of the MINSEQE experiment model, we can describe a 
single-cell sequencing experiment with a few additions and changes (Supplementary Table 
1). Each component is equivalent to a main experimental step. For each field we recommend 
using terms from a suitable ontology (like NCBI Taxonomy2 for species, UBERON3 for 
tissues, and Cell Ontology4,5 for cell types) or controlled vocabulary. Protocols should ideally 
be hosted in a public repository such as protocols.io (https://protocols.io) and include a unique 
protocol identifier.  
 
 
Supplementary Table 1. Descriptions of the components comprising the MINSEQE-derived 
guidelines for describing scRNA-Seq experiments. 
MINSEQE+ Component Description 
Biosource The characteristics of the biological sample material and 
experimental variables. Single cell experiments may 
have different starting points or several biosource 
transformation steps in the experimental flow, ranging 
from donor organism to final cell suspension. Any of 
these should be described with relevant attributes, as 
well as their interrelation.  
Single cell isolation Specific to single cell experiments is the cell isolation 
and singularisation information, for example the method 
how cells were dissected from tissue, sorted and 
enriched as well as visual quality checks prior to lysis. 
Library construction The library construction component comprises an overall 
description of the single-cell protocol, as well as more 
detailed information about the library preparation 
method, such as input fraction of biomolecule, primers 
used, strandedness, spike-in RNAs and information 
about barcodes for methods using multiplexing. 
Sequencing assay The sequencing assay refers to the sequencing of the 
library. It describes the sequencing mode and allows 
capture of technical replicate information such as 
whether the same library was sequenced multiple times 
or over different lanes and flow cells. 
 3 
Raw data  The raw sequencing output, usually in FASTQ format. 
Additional attributes capture a file’s identity (what type of 
read it contains), location and checksum. 
Processed data and post-
analysis information 
Analysis results of a single-cell experiment, such as 
gene expression matrix with count values per gene and 
cell. Some processed data is useful for analysing single-
cell experiments, such as a cell type definition that is 
determined as a result of a cell clustering or a list of cell 
barcodes. Although not within the “minimum” checklist, 
this information is helpful and recommended. 
Protocols Describes the procedures for transformation of the 
material or data from one experimental step to the next.  
Study and Publication General information about the study, such as a 
description and contributing authors, and a link to a 
published manuscript using the dataset. 
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2. Single cell-specific attributes 
 
In Supplementary Table 2, we describe the single cell-specific attributes that are captured 
for each component of the extended MINSEQE standard for scRNA-Seq datasets. 
 
Supplementary Table 2. List of suggested single-cell specific attributes with definitions and 
significance. Significance levels are defined as 1: Required for analysis (mandatory); 2: 
Greatly improves data utility (essential); 3: Additional relevant information that can help 
improve analysis. 
Attribute Description Significance  
Biosource 
Organism The species name of the donor organism. E.g. "Homo 
sapiens". 
1 
*other sample attributes Any attributes describing the sample, cell suspension 
or biological materials they were derived from (e.g. 
donor age, sex, strain, genotype, disease/health 
status, tissue, cell type) as well as other experimental 
factors introduced during the experiment (e.g. 
compound treatment, sampling time point). 
2 
Single cell isolation 
Tissue dissociation The method by which tissues are dissociated into 
single cells in suspension. Examples are "proteolysis", 
"mesh passage", "fine needle trituration".  3 
Cell enrichment  The method by which specific cell populations are 
sorted or enriched, e.g. "fluorescence-activated cell 
sorting (FACS)". 3 
Enrichment markers Description of the specificity markers used to isolate 
cell populations, e.g. "CD45+". 2 
Single cell isolation The method by which individual cells, nuclei, or another 
portion are separated for individual barcoding. 
Examples are "FACS", "microfluidics", "manual 
selection", "droplet-based cell isolation".  
2 
Single cell entity The type of single cell entity derived from isolation 
protocol e.g. "whole cell", "nucleus", "cell-cell 
multimer", "spatially encoded cell barcoding". 2 
Single cell quality metric For plate/well-based methods information about the 
well contents may be available. This can either be 
measured by visual inspection prior to cell lysis or 
defined by known parameters such as wells with 
several cells or no cells. This can be captured at a high 
level, e.g. “OK” or “not OK”, or with more specificity 
such as “debris”, “no cell”, "doublet", “50 cells”. 
2 
Cell number For droplet experiments, the number of cells used as 
input for the library preparation, e.g. "5000". 
2 
Single cell identifier  A unique identifier given to each individual cell, e.g. 
"cell 1". 
2 
Library construction 
Library construction The library construction method (including version) that 
was used, e.g. "Smart-Seq2", "Drop-Seq", "10X v3". 
1 
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Input molecule This is the specific fraction of biological macromolecule 
from which the sequencing library is derived, e.g. 
"polyA RNA". 
2 
Primer The type of primer used for reverse transcription, e.g. 
"oligo-dT" or "random" primer. This allows users to 
identify content of the cDNA library input e.g. enriched 
for mRNA. 
2 
Amplification method The method used to amplify RNA, e.g. "PCR" or "in 
vitro transcription".  
3 
Amplification cycles The number of cycles used to multiply the RNA 
molecules. 
3 
End bias The end of the cDNA molecule that is preferentially 
sequenced, e.g. 3/5 prime tag or end, or the full-length 
transcript. 
1 
Library strand The strandedness of the library, whether reads come 
from both strands of the cDNA or only from the first 
(antisense) or the second (sense) strand. 
1 
Spike in Spike-in RNAs are synthetic RNA molecules with 
known sequence that are added to the cell lysis mix. 
e.g. the External RNA Controls Consortium (ERCC) 
spike in set is commonly used in single-cell 
experiments. 
2 
Spike in dilution or 
concentration  
The final concentration or dilution (for commercial sets) 
of the spike in mix, e.g. "1:40,000" 
2 
Sequencing assay 
Library layout If the library was sequenced in single-end or paired-
end mode. 
2 
Instrument model The manufacturer and model of the sequencing 
machine, e.g. "Illumina HiSeq 2500". 
2 
Technical replicate group 
or library reference 
A common term for all runs/files belonging to the same 
cell or library. We suggest to use a stable sample 
accession from a biosample archive like BioSamples 
database6. Alternatively, the library ID can be 
referenced from which the files were generated. 
1 
Raw data files and sequences 
UMI barcode read The type of read that contains the UMI barcode: 
index1/index2/read1/read2. 
1 
UMI barcode offset The offset in sequence of the UMI identifying barcode. 
E.g. "16". 
1 
UMI barcode size The size of the UMI identifying barcode. E.g. "10". 1 
Cell barcode read The type of read that contains the cell barcode: 
index1/index2/read1/read2. 
1 
Cell barcode offset The offset in sequence of the cell identifying barcode. 
E.g. "0". 
1 
Cell barcode size The size of the cell identifying barcode. E.g. "16". 1 
cDNA read The type of read that contains the cDNA read: 
index1/index2/read1/read2. 
1 
cDNA read offset The offset in sequence for the cDNA read. E.g. "0". 1 
cDNA read size The size of the cDNA read. E.g. "98". 1 
Sample barcode read The type of read that contains the sample barcode: 
index1/index2/read1/read2. 
3 
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Sample barcode offset The offset in sequence of the sample identifying 
barcode. E.g. "0". 
3 
Sample barcode size The size of the sample identifying barcode (bp). E.g. 
"8". 
3 
Read 1 file  The name of the file that contains read 1. E.g. 
"File1_R1.fastq.gz". 
1 
Read 2 file The name of the file that contains read 2 (for paired-
end sequencing). E.g. "File1_R2.fastq.gz". 
1 
Index 1 file The name of the file that contains index read 1. E.g. 
"File1_I1.fastq.gz". 
1 
Index 2 file The name of the file that contains index read 2. E.g. 
"File1_I2.fastq.gz". 
1 
Checksum Result of a hash function calculated on the file content 
to assert file integrity. Commonly used algorithms are 
MD5 and SHA-1. E.g. 
"ab21a9c0f2007890fe2fbe48df0519f9". 
2 
White list barcode file 
 
A file containing the known cell barcodes in the 
dataset. 
3 
Cell- and sample-associated information derived from data analysis 
Inferred cell type Post analysis cell type declaration based on expression 
profile or known gene function identified by the 
performer, e.g. if a pool of cells are sequenced with the 
purpose of identifying new cell types or sub-
populations. Per cell, in addition to sample of origin 
metadata, any number of lineage, class, and subclass 
attributes that serve to group cells within the sample or 
set of samples can be declared. E.g. "type II bipolar 
neuron". 
2 
Post analysis cell/well 
quality 
Performer defined measure of whether the read output 
from the cell was included in the sequencing analysis. 
For example, cells might be excluded if a threshold 
percentage of reads did not map to the genome or if 
pre-sequencing quality measures were not passed. 
E.g. "pass" or "fail". 
2 
Protocols 
Single cell isolation 
protocol 
How were single cells separated into a single-cell 
suspension? 3 
Nucleic acid library 
construction protocol  
How was the cDNA library constructed? If a kit was 
used name, manufacturer, catalogue number, lot and 
date of manufacture should be included. 3 
Nucleic acid sequencing 
protocol 
How was the sequencing done, were any special 
parameters used? How many sequencing runs were 
done? Expected read lengths. 3 
Data analysis protocol What workflow was followed to derive results from raw, 
primary, and secondary data? How were cell types 
inferred? 3 
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3. Implementations 
Tabular Format 
MAGE-TAB is a spreadsheet-based format, developed to represent experimental metadata 
compliant with MIAME/MINSEQE7. A simple tabular format, such as MAGE-TAB is well 
suited for capturing information at the sample (i.e. cell) level. In a sequential way, it follows 
the sample through the stages of the experimental process, linking different entities from 
tissue/cell through different protocols for RNA extraction, sequencing library preparation and 
sequencing to the resulting data files. It is also able to express complex relationships between 
samples and data, such as different types of technical replicates. 
 
The Gene Expression team at EMBL-EBI has modified the original MAGE-TAB format, both 
the Investigation Description Format (IDF) and the Sample and Data Relationship Format 
(SDRF), to capture single-cell specific information. The SDRF has been expanded with 
single-cell specific terms as “Comment” columns. This allows users to provide all the 
information required for processing at the single-cell level within a single metafile. Moreover, 
scRNA-Seq datasets are annotated with the experiment type ontology term “RNA-seq of 
coding RNA from single cells” (EFO_0005684) in the IDF. In contrast, bulk RNA-Seq datasets 
are annotated as “RNA-seq of coding RNA” (EFO_0003738), allowing specific retrieval of 
only scRNA-Seq datasets, only bulk RNA-Seq datasets or both. In order to describe a 
scRNA-Seq experiment, the IDF should specify the following protocols: 1) sample collection 
protocol (EFO_0005518), 2) single cell isolation protocol (EFO term pending), 3) single cell 
nucleic acid library construction protocol (EFO term pending) and 4) single cell sequencing 
protocol (EFO_0008439). A complete list of MAGE-TAB fields used for archival in 
ArrayExpress and analysis in Single Cell Expression Atlas can be found at 
https://github.com/ebi-gene-expression-group/sc-metadata-fields.  
 
An example describing a Smart-Seq2 experiment in Drosophila melanogaster 
We have applied our minimum metadata standards to the Smart-Seq2 dataset generated by 
Li et al. in 20178. The IDF corresponding to study GSE100058, including a curated 
description of each protocol, can be downloaded here 
ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/atlas/sc_experiments/E-GEOD-100058/E-GEOD-
100058.idf.txt. 
 
The SDRF has been adapted to include single-cell specific information in order to enable re-
use and interpretation of single-cell experiments. Supplementary Table 3 summarises the 
metadata representation of a sample from the GSE100058 dataset. Here, in the case of the 
plate-based Smart-Seq2 library preparation protocol, one sample corresponds to one 
individual cell. The single-cell specific information entities are added as columns to the SDRF 
table to allow individual annotation of each cell.   
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Supplementary Table 3. Overview of the metadata fields applied to a sample of Smart-
Seq2 experiment GSE100058. 
SDRF field Ontology ID Example value Ontology ID 
biomaterial 
Source Name  GSM2670685  
Characteristics[organism] OBI_0100026 Drosophila melanogaster NCBITaxon_7227 
Characteristics[organism part] EFO_0000635 brain UBERON_0000955 
Characteristics[sex] PATO_0000047 mixed sex population EFO_0001271 
Characteristics[developmental 
stage] EFO_0000399 pupal stage FBdv_00005349 
Characteristics[genotype] EFO_0000513 GH146-GAL4  
Characteristics[cell type] EFO_0000324 olfactory projection neuron  
Characteristics[single cell quality]  OK  
Characteristics[well information]  1 cell  
single cell isolation 
Comment[single cell isolation]  FACS EFO_0009108 
single cell library preparation 
Comment[input molecule]  polyA RNA OBI_0000869 
Comment[library construction] OBI_0000711 smart-seq2 EFO_0008931 
Comment[end bias]  none  
Comment[primer]  oligo-dT  
Comment[spike in]  none  
Comment[library_strand]  not applicable  
Comment[library_layout]  PAIRED  
Comment[library_source]  
TRANSCRIPTOMIC 
SINGLE CELL  
Comment[library_strategy]  OTHER  
Comment[library_selection]  other  
Comment[ENA_experiment]  SRX2921940  
sequencing 
Comment[instrument_model] Illumina NextSeq 500  
sequencing data file 
Comment[ENA_run]  SRR5687154  
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An example describing a 10x experiment in Mus musculus 
In contrast to plate-based technologies, where each and every cell can be characterised, the 
high throughput of droplet-based single-cell technologies, such as Drop-Seq or 10x, makes 
it impractical to annotate cells individually in the SDRF. Moreover, the cells in the same 
sequencing reaction have identical metadata for the attributes that are known before the data 
analysis. Therefore, to describe a droplet-based experiment, information is captured in the 
SDRF at the level of the sequencing library, with each library typically containing a few 
thousand cells. 
 
E-MTAB-6429 is a 10x experiment comparing HPV16 E7 oncogene expressing mouse 
keratinocytes versus wild type cells9. The SDRF has four samples, describing the four 
sequencing libraries (2 wild type and 2 transgenic keratinocyte samples). Supplementary 
Table 4 lists the metadata fields used to annotate a sample in E-MTAB-6429. Here, additional 
fields are required to describe how the data (i.e. sequencing reads) for each cell and molecule 
can be retrieved. The IDF file can be downloaded from 
https://www.ebi.ac.uk/arrayexpress/files/E-MTAB-6429/E-MTAB-6429.idf.txt. 
 
 
 
Supplementary Table 4. Overview of the metadata fields applied to a sample of 10x 
experiment E-MTAB-6429. 
SDRF field Ontology ID Example value Ontology ID 
biomaterial 
Source Name  SAMEA5043064  
Characteristics[organism] OBI_0100026 Mus musculus NCBITaxon_10090 
Characteristics[strain] EFO_0005135 C57BL/6 EFO_0004472 
Characteristics[sex] PATO_0000047 female PATO_0000383 
Characteristics[age] EFO_0000246 10 to 12  
Characteristics[genotype] EFO_0000513 wild type genotype EFO_0005168 
Characteristics[organism part] EFO_0000635 epidermis UBERON_0001003 
Characteristics[sampling site] EFO_0000688 ear UBERON_0001690 
Characteristics[cell type] EFO_0000324 keratinocyte CL_0000312 
single cell isolation 
Comment[single cell isolation]  10x EFO_0008995 
single cell library preparation 
Comment[input molecule]  polyA RNA OBI_0000869 
Comment[library construction] OBI_0000711 10xV1  
Comment[end bias]  3 prime tag  
Comment[primer]  oligo-dT  
Comment[spike in]  none  
 10 
Comment[cDNA read]  read1  
Comment[cDNA offset]  0  
Comment[cDNA size]  98  
Comment[UMI barcode read]  read2  
Comment[UMI barcode offset]  0  
Comment[UMI barcode size]  1  
Comment[cell barcode read]  index1  
Comment[cell barcode offset]  0  
Comment[cell barcode size]  14  
Comment[sample barcode 
read]  index2  
Comment[sample barcode 
offset]  0  
Comment[sample barcode 
size]  8  
Comment[library_strand]  not applicable  
Comment[library_layout]  PAIRED  
Comment[library_source]  
TRANSCRIPTOMIC 
SINGLE CELL  
Comment[library_strategy]  OTHER  
Comment[library_selection]  PolyA  
Comment[ENA_experiment]  ERX2862695  
sequencing 
Comment[instrument_model]  Illumina NextSeq 500  
sequencing data file 
Comment[ENA_run]  ERR2856110  
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HCA JSON format 
The Human Cell Atlas (HCA) metadata standard is represented and validated by a JSON 
schema. The schema stipulates each attribute’s description, data type, programmatic name, 
human-readable name, example values, and guidelines for usage. By putting this information 
within the schema itself, everything needed to easily interpret and project metadata is 
available in one source. For example, the schema can be used to build tables and forms for 
data contributor input, to validate submitted metadata against the HCA metadata standard, 
to map to other metadata standards, and to convert metadata from one format to another 
(e.g. tabulated to nested JSON). 
 
Similar to MAGE-TAB, the entities described by JSON schema are designed to reflect the 
experimental design. Biomaterial entities of various types (e.g. donor, cell suspension) are 
arranged to reflect the experimental workflow. Process and protocol information is captured 
to describe the transformation of one biomaterial into another, for example transforming a 
specimen into a cell suspension through dissociation. Entity linking is relied upon to further 
add expressive context to the metadata, for example linking two different specimens to the 
same donor to reflect biological replicate samples. 
 
Biomaterials are also linked to data and supplementary data files which have their own set 
of associated metadata fields. Schema modularity affords fungibility to accurately represent 
experimental workflow, while the JSON schemas themselves ensure that the fields are tightly 
controlled and validated to maintain a high metadata standard. 
 
Examples are given in Supplementary Table 5 (Smart-Seq2 technology) and Supplementary 
Table 6 (10x technology). 
 
 
Supplementary Table 5. Metadata captured for a Smart-Seq2 HCA dataset. The subset of 
fields supplied by the data contributors are shown; unused fields are not shown. Contributor 
metadata data is not shown as there are many contributors per project. Link: 
https://data.humancellatlas.org/explore/projects/ae71be1d-ddd8-4feb-9bed-24c3ddb6e1ad. 
Metadata Field Metadata Value Scope 
Project 
Project short name Healthy and type 2 diabetes pancreas Per project 
Project title Single-cell RNA-Seq analysis of human pancreas from 
healthy individuals and type 2 diabetes patients 
Project description We used single-cell RNA-Sequencing to generate 
transcriptional profiles of endocrine and exocrine cell 
types of the human pancreas. Pancreatic tissue and 
islets were obtained from six healthy and four T2D 
cadaveric donors. Islets were cultured and dissociated 
into single-cell suspension. Viable individual cells were 
distributed via fluorescence-activated cell sorted (FACS) 
into 384-well plates containing lysis buffer. Single-cell 
cDNA libraries were generated using the Smart-Seq2 
protocol. Gene expression was quantified as reads per 
kilobase transcript and per million mapped reads 
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(RPKM) using rpkmforgenes. Bioinformatics analysis 
was used to classify cells into cell types without 
knowledge of cell types or prior purification of cell 
populations. We revealed subpopulations in endocrine 
and exocrine cell types, identified genes with interesting 
correlations to body mass index (BMI) in specific cell 
types and found transcriptional alterations in 
T2D.  Complementary whole-islet RNA-Seq data have 
also been deposited at ArrayExpress under accession 
number E-MTAB-5060 
(http://www.ebi.ac.uk/arrayexpress/experiments/E-
MTAB-5060). 
Supplementary links https://www.ebi.ac.uk/gxa/sc/experiments/E-MTAB-
5061/Results  
INSDC project accession ERP017126 
ArrayExpress accession E-MTAB-5061 
INSDC study accession PRJEB15401 
Authors Segerstolpe A||Palasantza A||Eliasson P||Andersson 
EM||Andreasson AC||Sun X||Picelli S||Sabirsh 
A||Clausen M||Bjursell MK||Smith DM||Kasper 
M||Ammala C||Sandberg R 
Per 
publication; 
zero or 
more per 
project Publication title Single-Cell Transcriptome Profiling of Human Pancreatic 
Islets in Health and Type 2 Diabetes 
DOI 10.1016/j.cmet.2016.08.020 
PMID 27667667 
Publication URL https://europepmc.org/abstract/MED/27667667  
Name - Per 
contributor; 
one or more 
per project 
Email - 
Phone number - 
Institute - 
Laboratory - 
Address - 
Country - 
Project role - 
ORCID ID - 
Corresponding contributor - 
Grant ID 648842 Per funder; 
one or 
more per 
project 
Organization European Research Council 
Donor 
Donor ID H1 Per donor 
Donor description Normal Donor 1 
NCBI taxon ID 9606 
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Genus species Homo sapiens 
Genus species ontology NCBITaxon:9606 
Is living no 
Biological sex male 
Known disease(s) normal 
Known disease(s) ontology PATO:0000461 
Organism age 43 
Organism age unit year 
Organism age unit ontology UO:0000036 
Development stage human adult stage 
Development stage 
ontology 
HsapDv:0000087 
Body mass index 30.8 
Test results HbA1c 5.0% 
Specimen 
Specimen ID H1_pancreas Per 
specimen, 
one or more 
per donor 
Specimen description Pancreas from normal donor H1 
Organ pancreas 
Organ ontology UBERON:0001264 
Organ part islet of Langerhans 
Organ part ontology UBERON:0000006 
Purchased specimen 
Manufacturer 
Prodo Laboratories Inc (Irvine, CA, USA)  
Cell suspension 
Cell suspension ID AZ_A7 Per cell 
suspension; 
one or more 
per 
specimen 
Cell suspension description AZ_A7 cell 
INSDC ID ERS1348479 
BioSample ID SAMEA4437030 
Plate label AZ 
Well label A7 
Cell quality OK 
Estimated cell count 1 
Sequence file 
File name AZ_A7.fastq.gz Per file; one 
or two per 
cell 
suspension 
(single or 
paired end) 
File format fastq.gz 
Read index read1 
Read length 43 
INSDC run ERR1630022 
INSDC experiment ERX1700355 
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Dissociation protocol 
Dissociation protocol ID dissociation_protocol_1 Zero or 
more per 
project 
Dissociation protocol 
description 
Islets were dissociated into single-cell suspension and 
viable individual cells were distributed by FACS into 384-
well plates containing lysis buffer. 
Publication DOI 10.1016/j.cmet.2016.08.020 
Dissociation method fluorescence-activated cell sorting 
Dissociation method 
ontology 
EFO:0009108 
Library preparation protocol 
Library preparation protocol 
ID 
library_preparation_protocol_1 Zero or 
more per 
project Library preparation protocol 
description 
Single-cell RNA-Seq libraries were generated as 
described in Picelli et al., 2014, Full-length RNA-Seq 
from single cells using Smart-Seq2, Nature Protocols. 
Publication DOI 10.1038/nprot.2014.006 
Input nucleic acid molecule polyA RNA 
Input nucleic acid molecule 
ontology 
OBI:0000869 
Nucleic acid source single cell 
Spike-in dilution 40000 
Spike-in kit Retail name External RNA Controls Consortium (ERCC) 
Spike-in kit Manufacturer Ambion, Life Technologies 
Library construction 
approach 
Smart-seq2 
Library construction 
approach ontology 
EFO:0008931 
Library construction kit 
Retail name 
Nextera XT kit 
Library construction kit 
Manufacturer 
Illumina 
End bias full length 
Primer poly-dT 
Strand unstranded 
Sequencing protocol 
Sequencing protocol ID sequencing_protocol_1 Zero or 
more per 
project 
Sequencing protocol 
description 
Libraries were sequenced on an Illumina HiSeq 2000, 
generating 43 bp single-end reads. 
Publication DOI 10.1038/nprot.2014.006 
Instrument manufacturer 
model 
Illumina HiSeq 2000 
Instrument manufacturer 
model ontology 
EFO:0004203 
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Paired end no 
Sequencing approach full length single cell RNA sequencing 
Sequencing approach 
ontology 
EFO:0008441 
 
 
Supplementary Table 6. Metadata captured for a 10x HCA dataset. The subset of fields 
supplied by the data contributors are shown; unused fields are not shown. Contributor 
metadata data is not shown as there are many contributors per project. Link: 
https://data.humancellatlas.org/explore/projects/005d611a-14d5-4fbf-846e-571a1f874f70. 
Metadata Field Metadata Value Scope 
Project 
Project short name HPSI human cerebral organoids Per project 
Project title Assessing the relevance of organoids to model inter-
individual variation 
Project description The purpose of this project is to assess the relevance 
of pluripotent stem cell-derived cerebral and liver 
organoids to recapitulate the variation in cell-type 
specific gene expression programs between 
individuals. Towards this aim, we will generate 
reference atlases of the developing cortex and liver 
from multiple individuals, derive iPSC lines from these 
same individuals, and determine if inter-individual gene 
expression variation is recapitulated in cerebral and 
liver organoids from the same individual from which we 
have reference maps. In parallel we will assess the 
genetic contribution to variability between organoids 
from different iPSCs of multiple human individuals that 
are available in existing iPSC resources (e.g. HipSci). 
Contact name - Per 
contributor; 
one or 
more per 
project 
Email - 
Phone number - 
Institution - 
Laboratory - 
Address - 
Country - 
Project role - 
ORCID ID - 
Corresponding contributor - 
Grant ID Not provided Per funder; 
one or 
more per 
project 
Organization Chan Zuckerberg Initiative 
Donor 
Donor ID HPSI0214i-wibj Per donor 
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Genus species Homo sapiens 
Genus species ontology NCBITaxon:9606 
NCBI taxon ID 9606 
BioSample ID SAMEA2398911 
Biological sex female 
Organism age 55-59 
Organism age unit year 
Organism age unit 
ontology 
UO:0000036 
Development stage adult 
Development stage 
ontology 
HsapDv:0000087 
Ethnicity European, White, British 
Ethnicity ontology HANCESTRO:0462 
Known disease(s) normal 
Known disease(s) 
ontology 
PATO:0000461 
Is living yes 
Specimen 
Specimen ID HPSI0214i-wibj_skin Per 
specimen; 
one or 
more per 
donor 
Genus species Homo sapiens 
Genus species ontology NCBITaxon:9606 
NCBI taxon ID 9606 
BioSample ID SAMEA2397844 
Organ skin of body 
Organ ontology UBERON:0002097 
Organ part skin epidermis 
Organ part ontology UBERON:0001003 
Known disease(s) normal 
Known disease(s) 
ontology 
PATO:0000461 
Cell line 
Cell line ID HPSI0214i-wibj_2 Per cell 
line; one or 
more per 
specimen 
Genus species Homo sapiens 
Genus species ontology NCBITaxon:9606 
NCBI taxon ID 9606 
BioSample ID SAMEA2627567 
Known disease normal 
Known disease ontology PATO:0000461 
Cell type pluripotent stem cell 
Cell type ontology CL:0002248 
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Model organ Stem cell 
Model organ ontology CL:0000034 
Catalog number 77650057 
Catalog URL http://www.hipsci.org/lines/#/lines/HPSI0214i-wibj_2 
Cell line type induced pluripotent 
Cell viability method Growth to confluence post-thaw 
Passage number 32 
Growth medium mTeSR1 
Feeder layer type feeder-free 
Drug treatment Cells were cultured in presence of Penicillin and 
Streptomycin 
Mycoplasma testing 
method 
PCR 
Mycoplasma testing 
results 
pass 
Date established 2014-10-24T00:00:00Z 
Organoid 
Organoid ID Org_HPSI0214i-wibj_2_1 Per 
organoid; 
one or 
more per 
cell line 
Genus species Homo sapiens 
Genus species ontology NCBITaxon:9606 
NCBI taxon ID 9606 
BioSample ID SAMEA5643382 
Organ brain 
Organ ontology UBERON:0000955 
Organoid age 62 
Organoid age unit day 
Organoid age unit 
ontology 
UO:0000033 
Organoid embedded in 
matrigel 
yes 
Organoid growth 
environment 
suspension 
Cell suspension 
Cell suspension ID HPSI_organoids_pooled_1 Per cell 
suspension
; one or 
more per 
organoid 
Genus species Homo sapiens 
Genus species ontology NCBITaxon:9606 
NCBI taxon ID 9606 
BioSample ID SAMEA5643396 
INSDC Sample accession ERS3447460 
Selected cell type neural cell 
Selected cell type 
ontology 
CL:0002319 
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Total estimated cell count 6316 
Sequence file 
File name GAC027_hOrg_HipSci_1_S5_L007_I1_001.fastq.gz Per file; 
two, three, 
or four per 
cell 
suspension 
(index1 and 
index2 
optional) 
File format fastq.gz 
Checksum 79b4def79acf215ca440a11570f1e97f 
Read index index1 
Lane index 7 
Read length 8 
INSDC run accession ERR3239100 
INSDC experiment 
accession 
ERX3266489 
iPSC induction protocol 
iPSC induction protocol 
ID 
ipsc_induction_protocol_1   
iPSC induction protocol 
description 
Fibroblasts are thawed, transduced using Cytotune 2.0 
Sendai virus (containing the Yamanaka genes 
encoding transcription factors Oct4, Sox2, cMyc and 
Klf4) and maintained until iPSC colony formation. 
Colonies are then picked and cultured to obtain a 
sizable yield of IPS cells, which are banked to a 
commercial grade standard. These banks then 
undergo quality checks to ensure the banks pass 
resuscitation tests and are free of mycoplasma. 
Zero or 
more per 
project 
Document filename hipsci-ipsc-pipeline.pdf   
Induction method sendai virus   
Pluripotent vector 
removed? 
yes   
iPSC induction kit Retail 
name 
Cytotune 1.0   
iPSC induction kit 
Manufacturer 
Thermofisher   
Pluripotency test HipSci Pluri test   
Differentiation protocol 
Differentiation protocol ID Org_Lanc_2014 Zero or 
more per 
project 
Differentiation protocol 
description 
Generation of cerebral organoids from human 
pluripotent stem cells. 
Publication DOI 10.1038/nprot.2014.158 
Differentiation method embryoid bodies 
Target pathway RHO, ROCK 
Differentiation validation 
method 
immunostaining 
Retail name ROCK inhibitor Y27632 
Small molecules Vitamin A (retinoic acid) 
Dissociation protocol 
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Dissociation protocol ID Cerebral_organoid_dissociation Zero or 
more per 
project 
Document filename Dissociation_protocol_130-092-628.pdf 
Dissociation method Papain-based enzymatic dissociation 
Dissociation method 
ontology 
EFO:0009128 
Retail name Neural Tissue Dissociation Kit 
Catalog number 130-092-628 
Manufacturer Miltenyi Biotec 
Library preparation protocol 
Library preparation 
protocol ID 
10x_3'_library_preparation Zero or 
more per 
project Library preparation 
protocol description 
10x Chromium single cell 3' v2 library preparation 
Document filename CG00052_SingleCell3_ReagentKitv2UserGuide_RevE
.pdf 
Nucleic acid source single cell 
Input nucleic acid 
molecule 
polyA RNA 
Input nucleic acid 
molecule ontology 
OBI:0000869 
Library construction 
approach 
10X 3' v2 sequencing 
Library construction 
approach ontology 
EFO:0009899 
End bias 3 prime tag 
Primer poly-dT 
Strand first 
Cell barcode-containing 
read 
Read 1 
Cell barcode offset 0 
Cell barcode length 16 
UMI barcode-containing 
read 
Read 1 
UMI barcode offset 15 
UMI barcode length 10 
Library construction kit 
Retail name 
10X Chromium Single Cell 3' Solution v2 Chemistry 
Library construction kit 
Manufacturer 
10X Genomics 
Sequencing protocol 
Sequencing protocol ID 10x_scRNASeq Zero or 
more per 
project 
Sequencing protocol 
description 
10x RNA sequencing 
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Document filename CG00052_SingleCell3_ReagentKitv2UserGuide_RevE
.pdf 
Instrument manufacturer 
and model 
Illumina HiSeq 2500 
Instrument manufacturer 
and model ontology 
EFO:0008565 
Paired end yes 
Sequencing approach tag based single cell RNA sequencing 
Sequencing approach 
ontology 
EFO:0008440 
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CIRM Tag Storm 
The CIRM CESCG (California Institute for Regenerative Medicine Center of Excellence in 
Stem Cell Genomics) is an initiative comprised of two dozen labs working on a wide variety 
of samples and assays. Biomaterials undergo extensive transformation. One such example 
is a donor with a disease condition having samples taken, the samples dissociated and 
sorted, PBMCs (peripheral blood mononucleocytes) isolated and reprogrammed into 
induced pluripotent stem cells, those cells are then differentiated and made into model 
systems such as cerebral organoids. Assay snapshots are taken during various steps to 
see how the biomaterials respond to being transformed. 
 
This complex biomaterial transformation is best captured utilizing a bottom-up approach to 
metadata, as labs have such differing experimental designs that it can be difficult to predict 
what information is necessary in a top-down schema. A subset of these metadata fields 
was initially developed as the Minimum Information about a Stem Cell Experiment (MISCE) 
metadata standard.  Subsequently, this metadata standard and schema has been modified 
as the CIRM Tag Storm format. Tag Storm is a human- and computer-readable format first 
developed by the UCSC Genome Browser. 
 
 
/* tagStorm - stuff to parse and interpret a genome-hub metadata.txt  
 * file, which is in a hierarchical format.  That is something like: 
 *  
 *     cellLine HELA 
 *     lab ucscCore 
 * 
 *         target H3K4Me3 
 *         antibody abCamAntiH3k4me3 
 *        
 *            file hg19/chipSeq/helaH3k4me3.narrowPeak.bigBed 
 *            format narrowPeak 
 * 
 *            file hg19/chipSeq/helaH3K4me3.broadPeak.bigBed 
 *            format broadPeak 
 * 
 *         target CTCF 
 *         antibody abCamAntiCtcf 
 * 
 *            file hg19/chipSeq/helaCTCF.narrowPeak.bigBed 
 *            format narrowPeak 
 * 
 *            file hg19/chipSeq/helaCTCF.broadPeak.bigBed 
 *            format broadPeak 
 * 
 * The file is broken into stanzas, that are separated from each other  
 * by blank lines. The blank lines can include whitespace, which is  
 * ignored.  Multiple blank lines can separate stanzas with no  
 * difference in meaning from a single blank line. Lines within a stanza  
 * start with a word which is the field label. 
 * A tab or a space (or multiple tabs or spaces) separate the label from 
 * the field contents. The label can't contain spaces. 
 * 
 * The file is interpreted so that lower level stanzas inherit tags from  
 * higher level ones. This file might be used as so: 
 *   struct tagStorm *tags = tagStormFromFile(“metadata.txt”); 
 *   struct hash *fileIndex = tagStormUniqueIndex(tags, “file”); 
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 *   struct tagStanza *stanza =  
 * hashMustFindVal(fileIndex,"hg19/chipSeq/helaCTCF.broadPeak.bigBed"); 
 *   char *target = tagFindVal(stanza, "target"); // Target is CTCF 
 * 
 * Most commonly indentation is done one tab-character per indentation  
 * level. Spaces may also be used. If spaces and tabs are mixed  
 * sometimes you get surprises. The tab-stop is interpreted as happening  
 * every 8 spaces. 
 * 
 */ 
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4. Methods 
Data submissions to ArrayExpress 
ArrayExpress is one of the major databases for functional genomics experiments and 
receives various kinds of single cell-based datasets. These include different kinds of scRNA-
Seq approaches, as well as single-cell DNA-Seq projects (e.g. single-cell ATAC-Seq, single-
cell MNase-Seq). 
 
The versatility of new technologies creates a demand to quickly adapt the metadata model 
and submission tool to new requirements. One challenge was to incorporate new file formats, 
such as the 10x Genomics file model that stores vital barcode sequences in a third or fourth 
FASTQ file, in addition to the usual two files for a paired-end sequencing run. These efforts 
lead to the creation of new tags in the SAM/BAM format specification to accommodate the 
single cell-specific barcodes together with the genomic/transcriptomic sequence. 
 
For directly submitted ArrayExpress experiments, metadata is curated at the level of 
submission, which allows curators to collect information from the data provider. The 
interaction with the data submitters is valuable to not only fill missing bits of information in 
the existing metadata schema, but also to learn about new, specific components of a 
particular protocol that have not been considered before. 
 
The Human Cell Atlas Data Coordination Platform of the Human Cell Atlas 
The Human Cell Atlas (HCA) Data Coordination Platform (DCP) metadata standard and 
schema implementation is maintained following an iterative, community-based, data-driven 
approach. The HCA metadata standard is developed in a transparent and open manner so 
that the HCA community can participate in the process. Data generators producing data from 
new cellular-resolution technologies can request updates to the HCA metadata standard in 
order to better capture information about new data types, for example 10x sequencing-
specific metadata fields. Data consumers can also request updates to the metadata standard 
to support analysis and visualization tool development. Community requests are reviewed by 
the HCA DCP Metadata Team who assess the value of the requested update to the entire 
HCA community and, in some cases, agree to adopt the change as part of the HCA metadata 
standard. The HCA DCP Metadata Team includes members from both the EMBL-EBI and 
UCSC, and it is  have made the most significant contribution to the schema and commits 
(now totalling close to 3,800) are tracked in the HCA GitHub repository 
(https://github.com/HumanCellAtlas/metadata-schema). 
 
Single cell technologies are a rapidly developing field. As such the HCA metadata standard 
needs to be able to adapt accordingly, with regular updates and a process for managing and 
tracking schema versions. By designing with this principle in mind, data requiring updates to 
the metadata standard can quickly be submitted to the HCA and made available to 
consumers. 
 
We anticipate that the HCA will expand to support other data modalities including controlled 
access data, model organism data, data from disease cohorts, proteomic, metabolomics, 
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genomic and possibly even data from genetically engineered biological samples. The HCA 
has therefore developed a flexible and modular data model that can be extended to new data 
types and modalities (https://data.humancellatlas.org/metadata/design-
principles/structure#motivation). By designing with the principle of flexibility in mind, the HCA 
metadata standard will be prepared to support all future data. 
 
Discussion with the wider community 
The reporting guidelines for scRNA-Seq experiments have been extensively discussed 
through a series of conference calls with the ArrayExpress, HCA, and Human BioMolecular 
Atlas Program (HuBMAP) communities. Original paper drafts and the metadata 
implementations of the different projects have been open for input and comparison during 
that time to support the derivation of the minimum, common terms required for reproducibility 
of scRNA-Seq experiments. 
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